Anbogen Therapeutics Inc. Listed by nightspire Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

People whose personal or professional information was held by Anbogen Therapeutics Inc. face uncertainty after a ransomware group listed the company on its leak site. The number of individuals affected remains unknown, and the company has not confirmed whether any data has been published or sold. The practical impact depends on what the stolen files contain. Without public confirmation of the contents or scale, those connected to the organisation have limited information on whether their details are at risk.

What happened

On March 25, 2026, the nightspire ransomware group listed Anbogen Therapeutics Inc. on its leak site. The listing states that internal files were exfiltrated during a ransomware attack. No information has been released on the number of records involved, the exact date of the intrusion, or the method used to gain access. The data referenced in the listing is not currently available for public view.

Who is nightspire?

Nightspire is a ransomware operation that follows the double-extortion model common among such groups. It typically encrypts systems, claims to copy data beforehand, and then posts victim names on a leak site to pressure payment. These groups often maintain a public presence to advertise their activity and to encourage other targets to negotiate. The listing of Anbogen is presented by the group as evidence of a successful operation, but independent confirmation of the claims has not been made public.

About Anbogen Therapeutics Inc.

Anbogen Therapeutics Inc. operates in the biotechnology sector, where organisations routinely manage research data, clinical trial records, regulatory submissions, and information about employees, partners, and trial participants. Such entities hold intellectual property and personal health-related information that can remain sensitive for years. A breach at a company of this type can affect both commercial interests and the privacy of individuals whose details appear in study or employment files.

What was likely exposed

The listing refers to internal files taken in a ransomware incident. No specific categories of data, such as names, contact details, or research documents, have been confirmed by the company or by independent sources. Organisations in this sector commonly store employee records, clinical information, and proprietary research materials, yet the exact contents of the exfiltrated files remain undisclosed.

What's at stake

Individuals named in the files could see their personal or health-related information circulated without consent. For the organisation, the exposure of research materials or business records can create competitive and regulatory concerns. Because the volume and nature of the data are not known, the full consequences cannot yet be measured.

What to do if you're exposed

Anyone who has worked with or participated in studies connected to Anbogen Therapeutics Inc. should watch for unusual account activity and consider changing passwords on any associated services. Enabling multi-factor authentication where available adds a basic layer of protection. Individuals can also run a free exposure scan of their email address against known breach data to check whether their information appears in public listings from this or other incidents.

AICompiled with AI assistance from public sources and published under our editorial standards.